XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Paid-in Capital
Retained Earnings
Beginning balance (in shares) at Sep. 30, 2022   30,880    
Beginning balance at Sep. 30, 2022 $ 939,286 $ 31 $ 859,856 $ 79,399
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income and comprehensive income 59,038     59,038
Stock-based compensation expense 3,258   3,258  
Shares issued under employee stock plans, net (in shares)   675    
Forfeiture and other settlements of restricted stock (in shares)   (3)    
Common stock redeemed for tax liability (in shares)   (205)    
Common stock redeemed for tax liability (2,597)   (2,597)  
Ending balance (in shares) at Mar. 31, 2023   31,347    
Ending balance at Mar. 31, 2023 998,985 $ 31 860,517 138,437
Beginning balance (in shares) at Dec. 31, 2022   31,347    
Beginning balance at Dec. 31, 2022 962,600 $ 31 858,839 103,730
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income and comprehensive income 34,707     34,707
Stock-based compensation expense 1,678   1,678  
Shares issued under employee stock plans, net (in shares)   3    
Forfeiture and other settlements of restricted stock (in shares)   (3)    
Ending balance (in shares) at Mar. 31, 2023   31,347    
Ending balance at Mar. 31, 2023 998,985 $ 31 860,517 138,437
Beginning balance (in shares) at Sep. 30, 2023   31,351    
Beginning balance at Sep. 30, 2023 1,102,819 $ 31 864,778 238,010
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income and comprehensive income 60,899     60,899
Stock-based compensation expense 3,062   3,062  
Stock option exercises (in shares)   2    
Stock option exercises 16   16  
Shares issued under employee stock plans, net (in shares)   376    
Shares issued under employee stock plans, net 1 $ 1    
Forfeiture and other settlements of restricted stock (in shares)   (10)    
Common stock redeemed for tax liability (in shares)   (172)    
Common stock redeemed for tax liability (5,220)   (5,220)  
Ending balance (in shares) at Mar. 31, 2024   31,547    
Ending balance at Mar. 31, 2024 1,161,577 $ 32 862,636 298,909
Beginning balance (in shares) at Dec. 31, 2023   31,533    
Beginning balance at Dec. 31, 2023 1,121,011 $ 32 861,241 259,738
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income and comprehensive income 39,171     39,171
Stock-based compensation expense 1,389   1,389  
Stock option exercises (in shares)   2    
Stock option exercises 16   16  
Shares issued under employee stock plans, net (in shares)   14    
Forfeiture and other settlements of restricted stock (in shares)   (2)    
Common stock redeemed for tax liability (10)   (10)  
Ending balance (in shares) at Mar. 31, 2024   31,547    
Ending balance at Mar. 31, 2024 $ 1,161,577 $ 32 $ 862,636 $ 298,909